2 assets in Small Intestine Carcinoma

Therapeutic assets addressing Small Intestine Carcinoma, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Fluorouracilum Small Intestine Carcinoma	Alliance for Clinical Trials in Oncology	N/A	D (30)
Oxaliplatin Small Intestine Carcinoma	Alliance for Clinical Trials in Oncology	N/A	D (30)